A Resource for Healthcare and Social Services Professionals
January 29, 2021
11:00 am–1:00 pm ET
This 4-hour course prepares nurses and other medical staff to manage office-based addiction treatment with buprenorphine and naltrexone.
Via Zoom
"The Nurse Care Manager Model of Office-Based Addiction Treatment" is an updated and condensed version of our traditional eight-hour “Essentials of Office Based Addiction Treatment” training. This four-hour training includes an overview of the current substance use epidemic; foundational education about chronic disease model of addiction, including the biology of addiction; an overview of the three medications used in addiction treatment; and discussion of evidence-based strategies for the initiation, stabilization, and ongoing maintenance and support of persons engaged in treatment for addiction. Particular attention is devoted to the importance of patient-centered care utilizing a nurse care manager model.
THIS TRAINING IS BEING HELD VIA ZOOM TELECONFERENCING TECHNOLOGY. In order to receive CE credit, you must have video enabled and turned on when you join the meeting so we can see your face, in addition to registering through this page. This Zoom information will be emailed to you ahead of the training.
Nurses and other clinical staff providing treatment for substance use disorders in an office-based setting. Intended for those involved with the MI-CARE project or those invited by Kaiser Permanente Washington or Indiana.
Director of the OBAT TTA+ program and founder and director of Boston Medical Center's OBAT Clinic.
Annie Potter, MSN, MPH, NP, CARN-APThe learner will: Define opioid use disorder; Explain methods used to evaluate patients for treatment with buprenorphine and injectable naltrexone; Identify the clinically relevant pharmacological characteristics of buprenorphine and buprenorphine/naloxone; and Outline tools for monitoring and supporting patients engaged in Medication for Opioid Use Disorder (MOUD).
Boston Medical Center Grayken Center for Addiction, Department of Public Health, National Drug Abuse Treatment Clinical Trials Network, (CTN), established by the National Institute on Drug Abuse (NIDA)
Boston Medical Center grants 4.00 hours to all RNS who attend, complete the evaluation, and complete the post-test. Boston Medical Center is approved as a provider of continuing professional development by the American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.